Riskpilot← Back to searchSign inGet full accessSeebreath AB
ABActiveOrg 5568303043Birger Jarlsgatan 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 20100 employees
Revenue 2024
SEK 8,3M
+7% vs 2023
EBITDA margin
51.7%
+18% vs 2023
Equity ratio
88.6%
Financial strength
Net profit 2024
SEK 3,5M
+282% vs 2023
| Revenue | SEK 8,3M | +7% |
| EBITDA | SEK 4,3M | +18% |
| Net profit | SEK 3,5M | +282% |
| Total assets | SEK 6,9M | -28% |
| Equity | SEK 6,1M | +128% |
| Employees | 0 | — |
Legal name
Seebreath AB
Org number
5568303043
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7 december 2010
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva utveckling, produktion och försäljning av medicintekniska produkter samt därmed förenlig verksamhet.
Address
Birger Jarlsgatan 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 7 472 | 12 155 | 9 090 | 10 249 | 11 683 | 13 407 | 7 791 | 8 328 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 1 948 | 3 074 | 2 297 | 3 713 | 3 975 | 3 961 | 4 151 | 8 819 | 3 659 | 4 307 |
| Depreciation & amort. | −247 | −332 | −231 | −263 | −183 | −176 | −108 | −89 | −71 | — |
| EBIT | 1 701 | 2 742 | 2 066 | 3 450 | 3 792 | 3 785 | 4 043 | 8 730 | 3 589 | 4 307 |
| Net financials | 14 | −98 | −118 | −91 | 103 | −334 | 161 | 33 | 20 | 45 |
| Profit before tax | 1 285 | 3 350 | 2 009 | 3 359 | 3 895 | 3 452 | 4 204 | 8 763 | −2 392 | 4 352 |
| Tax | −284 | −738 | −444 | −741 | −836 | −739 | −866 | −1 807 | — | −407 |
| Net profit | 1 001 | 2 612 | 1 565 | 2 618 | 3 059 | 2 713 | 3 338 | 6 956 | −1 899 | 3 453 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 596 | 4 568 | 3 948 | 3 872 | 4 523 | 4 543 | 7 708 | 9 273 | 9 630 | 6 931 |
| Equity | 1 326 | 3 038 | 2 003 | 3 120 | 3 580 | 3 293 | 4 130 | 7 587 | 2 688 | 6 141 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Short-term debt | 503 | 1 469 | 1 946 | 751 | 944 | 1 250 | 3 578 | 1 686 | 6 943 | 790 |
| Total debt | 503 | 1 469 | 1 946 | 751 | 944 | 1 250 | 3 578 | 1 686 | 6 943 | 790 |
EBITDA margin
51.7%
This company
15.8%
Market median
+227% vs market
20152024
Equity ratio
88.6%
This company
38.2%
Market median
+132% vs market
20152024
Return on equity
56.2%
This company
18.4%
Market median
+205% vs market
20152024
Net profit margin
41.5%
This company
8.1%
Market median
+412% vs market
20152024
Asset turnover
1.20×
This company
1.12×
Market median
+7% vs market
20152024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 2022 | — | — | |
AP Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
FF | Audit | 2021 | — | — |
MI Chief Auditor | Chief Auditor | 2022 | — | — |
BI Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AI Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
PJ Chief Auditor | Chief Auditor | 2022 | — | — |
EE Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Seebreath AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans-Fredrik Stefan Liljegren | Audit | 0 companies |
| Anders Patrik Tornström | Chief Executive Officer | 0 companies |
| Folke Fredrik Dellström | Audit | 0 companies |
| Magnus Ivar Thorling | Chief Auditor | 0 companies |
| Björn Ingemar Holmqvist | Chief Executive Officer | 0 companies |
| Arne Ingvar Johansson | Chief Executive Officer | 0 companies |
| Per Johan Engstam | Chief Auditor | 0 companies |
| Erik Eckhard Lissner | Chief Executive Officer | 0 companies |
| Paul Rickard Frans Krill | Deputy Board Member | 0 companies |
| Hai Leng Loh | Deputy Board Member | 0 companies |
| Jonas Fredrik Mella | Chairman | 0 companies |
| Oliver Humlen | Board of Directors | 0 companies |
| Jarl Johan Seltborg | Chairman | 0 companies |
| Rikard Akhtarzand | Board of Directors | 0 companies |
| Anna Sara Carina Glimmer | Board of Directors | 0 companies |
| Hanna Rebecca Lovisa Myhrman | Board of Directors | 0 companies |
| Jakob Sebastian Rutger af Robson | Board of Directors | 0 companies |
| Anette Maria Sjögren | Board of Directors | 0 companies |
| Johan Magnus Irwe | Board of Directors | 0 companies |
| Erik Staffan Bernstein Torstensson | Chairman | 0 companies |
| Andras Gedeon | Chairman | 0 companies |